---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-091383"
form_type: "8-K"
ticker: "ELUT"
cik: "0001708527"
company_name: "ELUTIA INC."
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T11:44:39.922746+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aziyo Q2 net sales $10.3M, net loss $10.6M; bone matrix recall drives $3M revenue reversal

## Summary
- Net sales $10.3M, down from $12.6M YoY; recall reversal of $3.0M of Q2 revenue.
- Gross margin 9.5% vs 38.8% prior year; recall cut gross profit by $5.0M and margin by 35%.
- Net loss $10.6M ($0.65 per share) vs $9.4M ($0.69 per share) YoY; cash $9.3M at June 30.
- Negotiating multiple LOIs to divest Orthopedic business; SimpliDerm up 32% YoY.
- CanGaroo RM 510(k) resubmission on track; working with FDA/CDC on viable bone matrix recall.

## SEC filing metadata
- accession: 0001104659-23-091383
- form_type: 8-K
- ticker: ELUT
- cik: 0001708527
- company_name: ELUTIA INC.
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708527/000110465923091383/0001104659-23-091383-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708527/000110465923091383/tm2323741d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-091383
- JSON: https://secwatch.observer/filing/0001104659-23-091383.json
- Plain text: https://secwatch.observer/filing/0001104659-23-091383.txt

## Key facts
- Earnings Releases
  ELUTIA INC. reported the second quarter ended June 30, 2023 results: revenue $10.3 million, net income $10.6 million, EPS $0.65 per share.
  - Period: the second quarter ended June 30, 2023
  - Revenue: $10.3 million
  - Net income: $10.6 million
  - EPS: $0.65 per share
  - Result: reported results
  source text: Net sales for the second quarter of 2023 were $10.3 million, compared to $12.6 million in the second quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708527/000110465923091383/0001104659-23-091383-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.